Strategy (NASDAQ:STRF), the world’s first Bitcoin Treasury Company, reported its financial results for the first quarter of 2026, highlighting steady growth in its core software business alongside the significant impact of digital asset volatility on its GAAP performance.
Silicon Labs (NASDAQ:SLAB) delivered a strong top-line performance for the first quarter of 2026, even as the company enters a period of corporate transition following the announcement of its acquisition by Texas Instruments.
HII (NYSE:HII) delivered a high-volume start to fiscal 2026, reporting double-digit revenue growth and a significant expansion of its contract backlog as the nation’s largest shipbuilder ramps up production for the U.S. Navy.
Intel (NASDAQ:INTC) shares vaulted 14% to a record high on Tuesday, fueled by a Bloomberg report that Apple (NASDAQ:AAPL) has initiated early-stage discussions with both Intel and Samsung Electronics about manufacturing its flagship processors within the United States.
Rockwell Automation (NYSE:ROK) reported significant top- and bottom-line growth for its fiscal second quarter, as the company’s pivot toward software-driven industrial solutions and smart manufacturing hardware continues to gain traction globally.
Duke Energy (NYSE:DUK) delivered a robust start to 2026, reporting a significant year-over-year earnings jump as the utility giant benefited from intensive infrastructure spending and favorable weather patterns across its core jurisdictions.
UL Solutions (NYSE:ULS) delivered a powerful performance in its first quarter of 2026, characterized by high organic growth and a sharp expansion in profitability that exceeded market expectations.
Marriott Vacations Worldwide (NYSE:VAC) reported a softer start to 2026, as a slight dip in contract sales and a shift in the financing environment pressured the bottom line.
IDEAYA Biosciences (NASDAQ:IDYA) marked a milestone first quarter in 2026, transitioning into a late-stage regulatory company following a decisive clinical win in its lead oncology program and the initiation of a rolling New Drug Application (NDA).
Integra LifeSciences (NASDAQ:IART) signaled a turning point in its operational recovery today, raising its full-year profit guidance even as it recorded a GAAP loss during a quarter defined by significant leadership changes and supply chain stabilization.
Enlight Renewable Energy 9NASDAQ:ENLT) delivered a high-growth first quarter, reporting a 54% increase in total revenues and income as the company aggressively scales its combined solar and storage portfolio across the United States, Europe, and the Middle East.
KBR (NYSE:KBR) reported a resilient start to fiscal 2026, leveraging a record-high backlog to navigate a temporary decline in revenue as large-scale contingency work in Europe begins to wind down.
